'Miracle' Weightloss Drugs Ozempic And Mounjaro Face Lawsuit Over Alleged Gastroparesis Side Effect
Portfolio Pulse from Benzinga Neuro
Novo Nordisk and Eli Lilly and Co., manufacturers of diabetes drugs Ozempic and Mounjaro, are facing a lawsuit over claims of causing gastroparesis. The lawsuit alleges a 'failure to warn' about the potential side effect. The law firm handling the case is investigating 400 other inquiries from clients across 45 states.
August 04, 2023 | 2:57 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Eli Lilly is facing a lawsuit over claims that its diabetes drug Mounjaro causes gastroparesis. This could potentially harm the company's reputation and financials.
The lawsuit could lead to financial penalties and damage the company's reputation, which could negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Novo Nordisk is facing a lawsuit over claims that its diabetes drug Ozempic causes gastroparesis. This could potentially harm the company's reputation and financials.
The lawsuit could lead to financial penalties and damage the company's reputation, which could negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100